Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Veru Inc (VERU)

Veru Inc (VERU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek GlobeNewswire - Tue Nov 5, 7:30AM CST

VERU : 0.6734 (+7.25%)
Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss GlobeNewswire - Mon Oct 21, 7:30AM CDT

VERU : 0.6734 (+7.25%)
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress GlobeNewswire - Wed Oct 16, 7:30AM CDT

VERU : 0.6734 (+7.25%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market FinancialNewsMedia - Tue Aug 6, 7:45AM CDT

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 7.60 (+1.47%)
NNVC : 1.3116 (+2.47%)
VERU : 0.6734 (+7.25%)
CMRX : 0.9199 (+0.68%)
SIGA : 6.45 (+2.87%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market GlobeNewswire - Tue Aug 6, 7:45AM CDT

NNVC : 1.3116 (+2.47%)
VERU : 0.6734 (+7.25%)
CMRX : 0.9199 (+0.68%)
SIGA : 6.45 (+2.87%)
Savings - Savings Piggybank White Background
3 Standout Penny Stocks to Watch This April Barchart - Tue Apr 16, 12:34PM CDT

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...

OCGN : 0.9121 (+1.24%)
VERU : 0.6734 (+7.25%)
DM : 4.43 (+0.69%)
$SPX : 5,971.57 (+0.38%)
Wall Street - shutterstock_93231562
Stock Index Futures Move Higher As Dovish Fed Comments Boost Hopes Of Fed Pivot Barchart - Fri Mar 3, 2023

March S&P 500 futures (ESH23) are up +0.21%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.34% this morning after three major U.S. benchmark indices closed higher on Thursday as investors cheered...

ESH23 : 3,957.05s (-0.09%)
NQZ24 : 20,850.50 (+0.10%)
CRM : 341.10 (+1.58%)
TSLA : 351.68 (+3.54%)
LHA.D.DX : 6.040 (-1.29%)
AI : 37.16 (+6.20%)
VERU : 0.6734 (+7.25%)
CHPT : 1.1550 (+2.21%)
COST : 964.27 (+0.90%)
MRVL : 92.78 (-0.17%)
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Veru Inc. (VERU) Investors of Class Action and to Actively Participate Business Wire - Mon Feb 6, 2023

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) and certain of...

VERU : 0.6734 (+7.25%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veru Inc. (VERU) Business Wire - Fri Feb 3, 2023

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Veru Inc. (“Veru”...

VERU : 0.6734 (+7.25%)
VERU SHAREHOLDER ALERT: Jakubowitz Law Reminds Veru Shareholders of a Lead Plaintiff Deadline of February 6, 2023 PR Newswire - Fri Feb 3, 2023

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Veru Inc. (NASDAQ: VERU). To...

VERU : 0.6734 (+7.25%)

Barchart Exclusives

Attention Long-Time SoFi Technologies Shareholders: Thursday's Unusual Options Activity Could Guide Your Next Investment Move Barchart - 8 minutes ago
Title: Summary: SoFi Technologies had the third-highest Vol/OI ratio in Thursday’s options trading. It was one of 20 unusually active options for the fintech growth stock. If you bought SOFI stock at the 2022 lows, it could be time to get protective. $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ A couple of interesting economic data points... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot